Rapid regression of atherosclerosis: insights from the clinical and experimental literature (original) (raw)
Blankenhorn DH and Hodis HN (1994) George Lyman Duff Memorial Lecture: arterial imaging and atherosclerosis reversal. Arterioscler Thromb14: 177–192 ArticleCASPubMed Google Scholar
Stein Y and Stein O (2001) Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions? Arterioscler Thromb Vasc Biol21: 183–188 ArticleCASPubMed Google Scholar
Stocker R and Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev84: 1381–1478 ArticleCASPubMed Google Scholar
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature362: 801–809 ArticleCASPubMed Google Scholar
Benditt EP and Benditt JM (1973) Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA70: 1753–1756 ArticleCASPubMedPubMed Central Google Scholar
Wissler RW and Vesselinovitch D (1976) Studies of regression of advanced atherosclerosis in experimental animals and man. Ann N Y Acad Sci275: 363–378 ArticleCASPubMed Google Scholar
Davies MJ et al. (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J69: 377–381 ArticleCASPubMedPubMed Central Google Scholar
Friedman M et al. (1957) Resolution of aortic atherosclerotic infiltration in the rabbit by phosphatide infusion. Proc Soc Exp Biol Med95: 586–588 ArticleCASPubMed Google Scholar
Williams KJ et al. (1984) Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect Biol Med27: 417–431 ArticleCASPubMed Google Scholar
Malinow MR (1983) Experimental models of atherosclerosis regression. Atherosclerosis48: 105–118 ArticleCASPubMed Google Scholar
Maruffo CA and Portman OW (1968) Nutritional control of coronary artery atherosclerosis in the squirrel monkey. J Atheroscler Res8: 237–247 ArticleCASPubMed Google Scholar
Armstrong ML et al. (1970) Regression of coronary atheromatosis in rhesus monkeys. Circ Res27: 59–67 ArticleCASPubMed Google Scholar
Daoud AS et al. (1981) Sequential morphologic studies of regression of advanced atherosclerosis. Arch Pathol Lab Med105: 233–239 CASPubMed Google Scholar
Williams KJ and Tabas I (2005) Lipoprotein retention—and clues for atheroma regression. Arterioscler Thromb Vasc Biol25: 1536–1540 ArticleCASPubMed Google Scholar
Williams KJ and Scanu AM (1986) Uptake of endogenous cholesterol by a synthetic lipoprotein. Biochim Biophys Acta875: 183–194 ArticleCASPubMed Google Scholar
Rodrigueza WV et al. (1997) Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools: implications for the treatment of atherosclerosis. Arterioscler Thromb Vasc Biol17: 2132–2139 ArticleCASPubMed Google Scholar
Williams KJ et al. (2000) Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol20: 1033–1039 ArticleCASPubMed Google Scholar
Rodrigueza WV et al. (1997) Remodeling and shuttling: mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler Thromb Vasc Biol17: 383–393 ArticleCASPubMedPubMed Central Google Scholar
Williams KJ et al. (1998) Structural and metabolic consequences of liposome–lipoprotein interactions. Adv Drug Deliv Rev32: 31–43 ArticleCASPubMed Google Scholar
Rodrigueza WV et al. (1998) Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles. Biochim Biophys Acta1368: 306–320 ArticleCASPubMed Google Scholar
Rader DJ et al. (2002) Infusion of large unilamellar vesicles (ETC-588) mobilize unesterified cholesterol in a dose-dependent fashion in healthy volunteers [abstract]. Arterioscler Thromb Vasc Biol22: a-53 Google Scholar
Williams KJ (1998) Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis. US Patent 5, 746, 223 Google Scholar
Miyazaki A et al. (1995) Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol15: 1882–1888 ArticleCASPubMed Google Scholar
Aikawa M and Libby P (2000) Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma. Ann NY Acad Sci902: 140–152 ArticleCASPubMed Google Scholar
Walsh A et al. (1989) High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J Biol Chem264: 6488–6494 ArticleCASPubMed Google Scholar
Plump AS et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell71: 343–353 ArticleCASPubMed Google Scholar
Ishibashi S et al. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest92: 883–893 ArticleCASPubMedPubMed Central Google Scholar
Tangirala RK et al. (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation100: 1816–1822 ArticleCASPubMed Google Scholar
Shah PK et al. (2001) High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice: potential implications for acute plaque stabilization. Circulation103: 3047–3050 ArticleCASPubMed Google Scholar
Rong JX et al. (2001) Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation104: 2447–2452 ArticleCASPubMed Google Scholar
Wolfrum C et al. (2005) Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med11: 418–422 ArticleCASPubMed Google Scholar
Williams KJ et al. (1992) Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem267: 13284–13292 ArticleCASPubMed Google Scholar
Ji ZS et al. (1993) Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem268: 10160–10167 ArticleCASPubMed Google Scholar
Williams KJ et al. (2005) Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II. Diabetes54: 1116–1122 ArticleCASPubMed Google Scholar
Kashyap VS et al. (1995) Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest96: 1612–1620 ArticleCASPubMedPubMed Central Google Scholar
Tsukamoto K et al. (1997) Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J Clin Invest100: 107–114 ArticleCASPubMedPubMed Central Google Scholar
Tangirala RK et al. (2001) Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem276: 261–266 ArticleCASPubMed Google Scholar
Thorngate FE et al. (2000) Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol20: 1939–1945 ArticleCASPubMed Google Scholar
Wientgen H et al. (2004) Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol24: 1460–1465 ArticleCASPubMed Google Scholar
Harris JD et al. (2002) Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE. Hum Mol Genet11: 43–58 ArticleCASPubMed Google Scholar
Rosenfeld ME et al. (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol20: 2587–2592 ArticleCASPubMed Google Scholar
Reis ED et al. (2001) Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg34: 541–547 ArticleCASPubMed Google Scholar
Llodra J et al. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA101: 11779–11784 ArticleCASPubMedPubMed Central Google Scholar
Trogan E et al. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci USA103: 3781–3786 ArticleCASPubMedPubMed Central Google Scholar
Trogan E et al. (2004) Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol24: 1714–1719 ArticleCASPubMed Google Scholar
Angeli V et al. (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity21: 561–574 ArticleCASPubMed Google Scholar
Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature392: 245–252 ArticleCASPubMed Google Scholar
Trogan E and Fisher EA (2005) Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions. Methods Mol Biol293: 221–231 CASPubMed Google Scholar
Forster R et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell99: 23–33 ArticleCASPubMed Google Scholar
Chawla A et al. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science294: 1866–1870 ArticleCASPubMed Google Scholar
Levin N et al. (2005) Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol25: 135–142 ArticleCASPubMed Google Scholar
Beaven SW and Tontonoz P (2006) Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med57: 313–329 ArticleCASPubMed Google Scholar
Feig JE et al. (2006) CCR7 is functionally required for atherosclerosis regression and is activated by LXR [abstract]. Arterioscler Thromb Vasc Biol26: e-50 Google Scholar
Lieu HD et al. (2003) Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation107: 1315–1321 ArticlePubMed Google Scholar
Rong JX et al. (2004) Normalization of plasma total cholesterol in LDL receptor deficient (Ldlr−/−), apoB100 mice decreases the size and macrophage content of advanced atherosclerotic lesions [abstract]. Arterioscler Thromb Vasc Biol24: e-72 Google Scholar
Raffai RL and Weisgraber KH (2002) Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J Biol Chem277: 11064–11068 ArticleCASPubMed Google Scholar
Raffai RL et al. (2005) Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Arterioscler Thromb Vasc Biol25: 436–441 ArticleCASPubMed Google Scholar
Ost CR and Stenson S (1967) Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid. Scand J Clin Lab Invest Suppl99: 241–245 CASPubMed Google Scholar
Brown BG et al. (1993) Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation87: 1781–1791 ArticleCASPubMed Google Scholar
Farmer JA and Gotto AM Jr (2002) Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis44: 415–428 ArticleCASPubMed Google Scholar
Stary HC et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol15: 1512–1531 ArticleCASPubMed Google Scholar
Brown BG et al. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med345: 1583–1592 ArticleCASPubMed Google Scholar
Callister TQ et al. (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med339: 1972–1978 ArticleCASPubMed Google Scholar
Nissen SE et al. (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA291: 1071–1080 ArticleCASPubMed Google Scholar
Nissen SE et al. (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA295: 1556–1565 ArticleCASPubMed Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA285: 2486–2497
Wiviott SD et al. (2005) Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol46: 1411–1416 ArticleCASPubMed Google Scholar
O'Leary DH and Polak JF (2002) Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol90: 18L–21L ArticlePubMed Google Scholar
Taylor AJ et al. (2006) The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3. Curr Med Res Opin22: 2243–2250 ArticleCASPubMed Google Scholar
Taylor AJ et al. (2004) Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation110: 3512–3517 ArticleCASPubMed Google Scholar
Nissen SE et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA290: 2292–2300 ArticleCASPubMed Google Scholar
Tardif JC et al. (2007) Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA297: 1675–1682 ArticlePubMed Google Scholar
Barter PJ et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med357: 2109–2122 ArticleCASPubMed Google Scholar
Nissen SE et al. (2007) Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med356: 1304–1316 ArticleCASPubMed Google Scholar
Kastelein JJ et al. (2007) Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med356: 1620–1630 ArticleCASPubMed Google Scholar
Zhong S et al. (1996) Increased coronary heart disease in Japanese–American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest97: 2917–2923 ArticleCASPubMedPubMed Central Google Scholar
Curb JD et al. (2004) A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res45: 948–953 ArticleCASPubMed Google Scholar
Brousseau ME (2005) Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov Today10: 1095–1101 ArticleCASPubMed Google Scholar
Nicholls SJ et al. (2007) Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA297: 499–508 ArticleCASPubMed Google Scholar
Skålén K et al. (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature417: 750–754 ArticlePubMedCAS Google Scholar
Pentikainen MO et al. (2002) Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler Thromb Vasc Biol22: 211–217 ArticleCASPubMed Google Scholar
Gustafsson M et al. (2007) Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ Res101: 777–783 ArticleCASPubMed Google Scholar
Watanabe N and Ikeda U (2004) Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep6: 112–120 ArticlePubMed Google Scholar
Liu ML et al. (2007) Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol27: 430–435 ArticleCASPubMed Google Scholar
Field H Jr et al. (1960) Dynamic aspects of cholesterol metabolism in different areas of the aorta and other tissues in man and their relationship to atherosclerosis. Circulation22: 547–558 ArticleCASPubMed Google Scholar
Guyton JR and Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol16: 4–11 ArticleCASPubMed Google Scholar
Frias JC et al. (2006) Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett6: 2220–2224 ArticleCASPubMed Google Scholar
Bisoendial RJ et al. (2003) Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation107: 2944–2948 ArticlePubMed Google Scholar
Kaul S et al. (2004) Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex. J Am Coll Cardiol44: 1311–1319 ArticleCASPubMed Google Scholar
Constantinides P (1981) Overview of studies on regression of atherosclerosis. Artery9: 30–43 CASPubMed Google Scholar
Pitt B (2005) Low-density lipoprotein cholesterol in patients with stable coronary heart disease—is it time to shift our goals? N Engl J Med352: 1483–1484 ArticleCASPubMed Google Scholar
Kastelein JJ et al. (2006) Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation114: 1729–1735 ArticleCASPubMed Google Scholar
Cuchel M et al. (2007) Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med356: 148–156 ArticleCASPubMed Google Scholar
Rader DJ (2007) Illuminating HDL—is it still a viable therapeutic target? N Engl J Med357: 2180–2183 ArticleCASPubMed Google Scholar
Zavoico GB (2003) Emerging Cardiovascular Therapeutics. Cambridge, MA, USA, June 10–11, 2003. Cardiovasc Drug Rev21: 246–253 ArticlePubMed Google Scholar